Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of the American Heart Association|July 17, 2015
S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial InfarctionKonstantinos E Hatzistergos, Ellena C Paulino, Raul A Dulce, et al.
JACC. Basic to Translational Science|December 9, 2020
Rejuvenation of Senescent Endothelial Progenitor Cells by Extracellular Vesicles Derived From Mesenchymal Stromal CellsLiyong Wang, Jianqing Wei, Andrea Da Fonseca Ferreira, et al.
Journal of the American Heart Association|February 22, 2022
S-Nitrosoglutathione Reductase Deficiency Causes Aberrant Placental S-Nitrosylation and PreeclampsiaShathiyah Kulandavelu, Raul A Dulce, Christopher I Murray, et al.
Frontiers in Medicine|April 5, 2021
Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 PatientsMaria Ines Mitrani, Michael A Bellio, Anthony Sagel, et al.
Molecular and Cellular Biochemistry|August 27, 2021
Characterization of extracellular vesicle miRNA identified in peripheral blood of chronic pancreatitis patientsChirag S Desai, Aisha Khan, Michael A Bellio, et al.
Cytotherapy|September 20, 2021
Amniotic fluid-derived extracellular vesicles: characterization and therapeutic efficacy in an experimental model of bronchopulmonary dysplasiaMichael A Bellio, Karen C Young, Julian Milberg, et al.
Stem Cells Translational Medicine|March 17, 2022
Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary DysplasiaMerline Benny, Benjamin Courchia, Sebastian Shrager, et al.
Stem Cells Translational Medicine|June 27, 2022
Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary HypertensionMayank Sharma, Michael A Bellio, Merline Benny, et al.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Frontiers in Cell and Developmental Biology|June 25, 2021
The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious DiseasesAisha Khan, Michael A Bellio, Ivonne H Schulman, et al.
Pageof 2